Afatinib (Standard)
Based on 1 Customer Validation
Afatinib (Standard) is the analytical standard of Afatinib. This product is intended for research and analytical applications. Afatinib (BIBW 2992) is an orally active, potent and irreversible dual specificity inhibitor of ErbB family (EGFR and HER2), with IC50 values of 0.5 nM, 0.4 nM, 10 nM and 14 nM for EGFRwt, EGFRL858R, EGFRL858R/T790M and HER2, respectively. Afatinib can be used for the research of esophageal squamous cell carcinoma (ESCC), non-small cell lung cancer (NSCLC) and gastric cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- Pureté : 97.64%
- CAS No.: 850140-72-6
- Formule: C24H25ClFN5O3
- Masse moléculaire:485.94
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Product Information
Information
Application
The compound is the grade of analytical standard, which is the reference standard supplied assay. It is commonly used in qualitative, quantitative and methodological research experiments in HPLC, GC and MS.
Chemical Information
-
CAS No. 850140-72-6
-
Appearance Solid
-
Masse moléculaire 485.94
-
Formule C24H25ClFN5O3
-
Color White to off-white
-
SMILES
O=C(NC1=C(C=C2C(C(NC3=CC(Cl)=C(C=C3)F)=NC=N2)=C1)O[C@H]4CCOC4)/C=C/CN(C)C
-
Synonyms
BIBW 2992 (Standard)
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
-
SDS (557 KB)
- English - EN (557 KB)
- Français - FR (557 KB)
- Deutsch - DE (557 KB)
- Norwegian - NO (557 KB)
- Español - ES (557 KB)
- Swedish - SV (557 KB)
- Italian - IT (557 KB)
- Korean - KR (557 KB)
- Portuguese - PT (557 KB)
-
Instruction de manipulation (2659 KB)
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
Keywords
- Afatinib (Standard)
- 850140-72-6
- BIBW 2992 (Standard)
- Reference Standards
- EGFR
- Autophagy
- Apoptosis
- c-Met/HGFR
- Akt
- p38 MAPK
- Epidermal growth factor receptor
- ErbB-1
- HER1
- PKB
- Protein kinase B
- NSCLC
- H1666
- H3255
- NCI-H1975
- NIH-3T3 cells
- A431
- ESCC
- HER2
- AKT
- HKESC-1
- HKESC-2
- SLMT-1
- EC-1
- anticancer
- orally active
- lung cancer
- Inhibitor
- inhibitor
- inhibit